Welcome to LookChem.com Sign In|Join Free

CAS

  • or

204913-01-9

Post Buying Request

204913-01-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

204913-01-9 Usage

General Description

1-[(3S,1R)-3-N-BOC-aminocyclopentyl]-1-ethanone is a compound with the chemical formula C13H23NO3. It is a derivative of cyclopentylamine and is commonly used in the synthesis of pharmaceuticals and other organic compounds. The "1-[(3S,1R)-3-N-BOC-aminocyclopentyl]-1-ethanone" group refers to the specific arrangement of atoms within the molecule, with the "BOC" group standing for tert-butyloxycarbonyl, which is a protective group commonly used in organic synthesis to protect amines from undesirable reactions. 1-[(3S,1R)-3-N-BOC-aminocyclopentyl]-1-ethanone is important in the development of new drugs and other bioactive compounds, and its molecular structure makes it a valuable building block for organic chemistry research.

Check Digit Verification of cas no

The CAS Registry Mumber 204913-01-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,4,9,1 and 3 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 204913-01:
(8*2)+(7*0)+(6*4)+(5*9)+(4*1)+(3*3)+(2*0)+(1*1)=99
99 % 10 = 9
So 204913-01-9 is a valid CAS Registry Number.

204913-01-9Upstream product

204913-01-9Relevant articles and documents

1,3,4-OXADIAZOLONE COMPOUND AND MEDICINE

-

Paragraph 0336; 0479; 0480, (2021/09/24)

The purpose of the present invention is to provide a compound having PIM inhibitory activity. Examples of the present invention include 1,3,4-oxadiazolone compounds represented by the following formula [1], and pharmaceutically acceptable salts, and solvates thereof. The compounds of the present invention have PIM inhibitory activity. In addition, since the compounds of the present invention have PIM inhibitory activity, the compounds of the present invention are useful as therapeutic agents for systemic lupus erythematosus, lupus nephritis, etc.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 204913-01-9